lg 100268 has been researched along with oleanolic acid in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (83.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blanchard, SG; Gribble, GW; Honda, T; Leesnitzer, LM; Mangelsdorf, DJ; Plunket, KD; Porter, WW; Sporn, MB; Suh, N; Wang, Y; Willson, TM | 1 |
Andreeff, M; Contractor, R; Issa, JP; Kogan, SC; Kondo, Y; Konoplev, S; Konopleva, M; Ling, X; Nagaoka, I; Ohsaka, A; Shi, Y; Tabe, Y; Tsao, T; Tsutsumi-Ishii, Y; Watt, JC | 1 |
Black, CC; Dmitrovsky, E; Gribble, GW; Honda, T; Lamph, WW; Liby, K; Liu, X; Risingsong, R; Royce, DB; Sporn, MB; Sporn, TA; Williams, CR; Yore, MM | 1 |
Albini, A; Gribble, GW; Honda, T; Lamph, WW; Liby, K; Risingsong, R; Royce, DB; Sogno, I; Sporn, MB; Vannini, N; Williams, CR; Yore, MM | 1 |
Liby, K; Ma, T; Risingsong, R; Royce, DB; Sporn, MB; Williams, CR; Yore, MM | 1 |
Hruban, RH; Liby, KT; Maitra, A; Risingsong, R; Royce, DB; Sporn, MB; Williams, CR | 1 |
6 other study(ies) available for lg 100268 and oleanolic acid
Article | Year |
---|---|
A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gamma.
Topics: 3T3 Cells; Adipocytes; Animals; Cell Differentiation; CREB-Binding Protein; Drug Synergism; Ligands; Methylation; Mice; Nicotinic Acids; Nuclear Proteins; Nuclear Receptor Co-Repressor 1; Oleanolic Acid; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Repressor Proteins; Retinoid X Receptors; Rosiglitazone; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Trans-Activators; Transcription Factors; Transcriptional Activation | 2000 |
PPARgamma-active triterpenoid CDDO enhances ATRA-induced differentiation in APL.
Topics: Acetylation; Animals; Antineoplastic Agents; Apoptosis; Cell Differentiation; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Histones; Humans; Leukemia, Promyelocytic, Acute; Mice; Mice, Transgenic; Nicotinic Acids; Oleanolic Acid; PPAR gamma; Promoter Regions, Genetic; Protein Processing, Post-Translational; Receptors, Retinoic Acid; Response Elements; RNA, Small Interfering; Tetrahydronaphthalenes; Tretinoin | 2007 |
The rexinoid LG100268 and the synthetic triterpenoid CDDO-methyl amide are more potent than erlotinib for prevention of mouse lung carcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Cell Line, Tumor; Erlotinib Hydrochloride; Female; Lung; Lung Neoplasms; Mice; Nicotinic Acids; Oleanolic Acid; Protein Kinase Inhibitors; Quinazolines; Tetrahydronaphthalenes | 2008 |
Prevention and treatment of experimental estrogen receptor-negative mammary carcinogenesis by the synthetic triterpenoid CDDO-methyl Ester and the rexinoid LG100268.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Movement; Drug Synergism; Endothelial Cells; Female; Humans; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; Mice; Mice, Transgenic; Neovascularization, Pathologic; Nicotinic Acids; Oleanolic Acid; Receptor, ErbB-2; Receptors, Estrogen; Tetrahydronaphthalenes | 2008 |
Triterpenoids CDDO-methyl ester or CDDO-ethyl amide and rexinoids LG100268 or NRX194204 for prevention and treatment of lung cancer in mice.
Topics: Adenocarcinoma; Animals; Cell Proliferation; Fatty Acids, Unsaturated; Female; Ligands; Lung Neoplasms; Macrophages; Mice; Mice, Inbred A; Nicotinic Acids; Oleanolic Acid; Rats; Tetrahydronaphthalenes; Urethane | 2009 |
Synthetic triterpenoids prolong survival in a transgenic mouse model of pancreatic cancer.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Disease Models, Animal; Mice; Mice, Transgenic; Nicotinic Acids; Oleanolic Acid; Pancreatic Neoplasms; Signal Transduction; Tetrahydronaphthalenes | 2010 |